Back Login for AI Analysis

    NAUT (STOCKS)

    Nautilus Biotechnolgy, Inc. Common Stock

    $2.300000
    +0.060000 (+2.68%)
    Prev close: $2.240000
    Company Information
    Exchange
    XNAS
    Sector
    Health Technology
    Industry
    Biotechnology
    CEO
    Sujal M. Patel
    Asset Type
    stocks
    Website
    Visit
    Fundamentals
    Market Cap
    $286.56M
    Employees
    124
    P/E (TTM)
    -4.98
    P/B (TTM)
    1.97
    Dividend Yield
    Technical Indicators
    SMA 10
    SMA 20
    SMA 50
    EMA 9
    EMA 21
    RSI
    MACD State

    Analyst Recommendations
    3
    Strong Buy
    4
    Buy
    1
    Hold
    0
    Sell
    Recent News

    No recent news found for this ticker.

    Earnings Surprises
    Period Actual Estimate Surprise Surprise %
    Mar 2026 (Q1)
    $-0.12 $-0.15 +0.0279 +18.86%
    Dec 2025 (Q4)
    $-0.11 $-0.14 +0.0328 +22.97%
    Sep 2025 (Q3)
    $-0.11 $-0.15 +0.0430 +28.10%
    Jun 2025 (Q2)
    $-0.12 $-0.16 +0.0381 +24.10%
    Financial Statements
    TTM (Mar 2026)
    Nonoperating Income/Loss $7.03M
    Operating Expenses $64.12M
    Research and Development $39.28M
    Income/Loss From Continuing Operations After Tax -$57.09M
    Income/Loss From Continuing Operations Before Tax -$57.09M
    Income Tax Expense/Benefit $0.00
    Net Income/Loss -$57.09M
    Net Income/Loss Attributable To Noncontrolling Interest $0.00
    Net Income/Loss Attributable To Parent -$57.09M
    Net Income/Loss Available To Common Stockholders, Basic -$57.09M
    Participating Securities, Distributed And Undistributed Earnings/Loss, Basic $0.00
    Preferred Stock Dividends And Other Adjustments $0.00
    Basic Earnings Per Share -$0.46
    Diluted Earnings Per Share -$0.46
    Basic Average Shares 379,182,532
    Diluted Average Shares 379,182,532
    Assets $177.78M
    Current Assets $98.83M
    Cash $95.90M
    Inventory $300.00K
    Other Current Assets $2.63M
    Noncurrent Assets $78.95M
    Fixed Assets $3.64M
    Other Non-current Assets $75.31M
    Liabilities $33.36M
    Current Liabilities $8.34M
    Accounts Payable $1.19M
    Wages $2.41M
    Other Current Liabilities $4.74M
    Noncurrent Liabilities $25.02M
    Equity $144.42M
    Equity Attributable To Noncontrolling Interest $0.00
    Equity Attributable To Parent $144.42M
    Liabilities And Equity $177.78M
    Net Cash Flow From Operating Activities -$49.86M
    Net Cash Flow From Operating Activities, Continuing -$49.86M
    Net Cash Flow From Investing Activities $29.95M
    Net Cash Flow From Investing Activities, Continuing $29.95M
    Net Cash Flow From Financing Activities $1.30M
    Net Cash Flow From Financing Activities, Continuing $1.30M
    Net Cash Flow -$18.61M
    Net Cash Flow, Continuing -$18.61M
    Comprehensive Income/Loss -$57.37M
    Comprehensive Income/Loss Attributable To Noncontrolling Interest $0.00
    Comprehensive Income/Loss Attributable To Parent -$57.37M
    Other Comprehensive Income/Loss -$57.37M
    Other Comprehensive Income/Loss Attributable To Parent -$280.00K